Biophytis (BPTS) News Today

$0.75

-0.02 (-2.61%)

(As of 11/28/2023 ET)

Compare

Today's Range: $0.74
▼
$0.77
50-Day Range: $0.69
▼
$1.59
52-Week Range: $0.65
▼
$9.02

Volume: 3,715 shs
Average Volume: 466,651 shs
Market Capitalization: $5.59 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.00

Stock Analysis Analyst Forecasts Chart Competitors Financials Headlines SEC Filings Short Interest Social Media

Source

Source	Headline
	Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil finance.yahoo.com - October 30 at 1:27 AM
	Biophytis ADS Fall 8.5% in After Receiving Nasdaq Notice marketwatch.com - October 27 at 7:53 PM
	Biophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panel finance.yahoo.com - October 27 at 7:53 PM
	Biophytis shares surge 41% following Covid partnership with France's Skyepharma proactiveinvestors.com - September 29 at 11:08 PM
	Biophytis (BPTS) Soars 73% on Partnership With Skyepharma finance.yahoo.com - September 26 at 12:45 PM
	Why Biophytis (BPTS) Shares Are Sky-Rocketing benzinga.com - September 25 at 3:20 PM
	Biophytis Shares Surge 79% Following Covid-19 Partnership With Skyepharma markets.businessinsider.com - September 25 at 3:20 PM
	marketbeat.com - September 25 at 11:04 AM
	Biophytis Shares Rise 41% After Partnership Deal With Skyepharma marketwatch.com - September 25 at 10:20 AM
	Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101) finance.yahoo.com - September 25 at 10:20 AM
	Why Is Biophytis (BPTS) Stock Up 49% Today? msn.com - September 25 at 10:20 AM
	Biophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101) finance.yahoo.com - September 25 at 10:20 AM
	Biophytis Provides an Update on its Early Access Programs for Sarconeos in the Treatment of Severe Forms of COVID-19 finanznachrichten.de - September 20 at 7:58 PM
	Biophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19 finance.yahoo.com - September 19 at 7:50 AM
	Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer finance.yahoo.com - September 14 at 9:24 AM
	Biophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopenia finanznachrichten.de - September 11 at 2:53 AM
	Biophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in Sarcopenia finance.yahoo.com - September 11 at 2:53 AM
	Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York finance.yahoo.com - September 4 at 5:38 PM
	Biophytis Announces Next Regulatory Steps in Europe and the United States for its COVA Project finance.yahoo.com - August 16 at 2:28 AM
	Why Is Biophytis (BPTS) Stock Up 18% Today? msn.com - August 8 at 9:33 AM
	Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe finance.yahoo.com - August 8 at 9:33 AM
	Biophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 Treatment marketwatch.com - July 20 at 2:25 PM
	Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19 finance.yahoo.com - July 20 at 9:25 AM
	Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19 finance.yahoo.com - July 20 at 9:25 AM
	Biophytis Shares Drop 12% on Direct Offering Pricing marketwatch.com - July 19 at 1:35 PM
	marketbeat.com - July 19 at 10:09 AM
	Biophytis Announces USD3.8 Million Registered Direct Offering finanznachrichten.de - July 19 at 8:34 AM
	Biophytis Announces $3.8 Million Registered Direct Offering finance.yahoo.com - July 19 at 8:34 AM
	iCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers pack seekingalpha.com - July 18 at 3:17 PM
	Why Are Biophytis Shares Skyrocketing Today? benzinga.com - July 18 at 3:17 PM
	Biophytis and SEQENS will together produce Sarconeos active compound msn.com - July 18 at 10:17 AM
	Biophytis Reports Clinical Results for Sarconeos in Sarcopenia Treatment at the 16th SCWD International Congress finanznachrichten.de - June 19 at 9:14 AM
	Biophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International Congress finance.yahoo.com - June 19 at 9:14 AM
	Biophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adopted finance.yahoo.com - June 16 at 7:02 PM
	Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June finance.yahoo.com - June 5 at 8:37 AM
	Biophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19 finance.yahoo.com - May 26 at 5:15 AM
	Biophytis ticks higher after presenting COVID drug data at conference msn.com - May 25 at 9:13 AM
	Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference finance.yahoo.com - May 25 at 9:13 AM
	Successful Capital Increase for Biophytis with EUR2.3 million Raised marketwatch.com - May 11 at 6:48 PM
	marketbeat.com - May 11 at 9:33 AM
	Successful capital increase for Biophytis with 2.3 million raised markets.businessinsider.com - May 11 at 8:45 AM
	Successful Capital Increase for Biophytis with €2.3 million Raised finance.yahoo.com - May 11 at 8:45 AM
	Successful Capital Increase for Biophytis with €2.3 million Raised finance.yahoo.com - May 11 at 8:45 AM
	Biophytis Launches a Round of Fundraising for Approximately 2 Million Euros finance.yahoo.com - May 10 at 3:54 PM
	marketbeat.com - May 10 at 12:57 PM
	Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos for the Treatment of COVID-19 finanznachrichten.de - May 9 at 5:10 AM
	Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the Treatment of COVID-19 finance.yahoo.com - May 9 at 5:10 AM
	Biophytis Strengthens its Management Team finance.yahoo.com - May 2 at 7:47 AM
	Biophytis Regains Compliance with NASDAQ Minimum Bid Price Requirement finance.yahoo.com - April 19 at 8:23 AM
	Biophytis Announces 2022 Financial Results and 2023 Perspectives finance.yahoo.com - April 18 at 10:32 AM

Get Biophytis News Delivered to You Automatically

BPTS Media Mentions By Week

BPTS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BPTS
News Sentiment
▼
1.87

0.87
▲
Average
Medical
News Sentiment

BPTS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BPTS Articles
This Week
▼
1

1
▲
BPTS Articles
Average Week

Get Biophytis News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:BPTS) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Biophytis (BPTS) News Today

BPTS Media Mentions By Week

BPTS Media Sentiment

BPTS News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info